bg-title

Shrestha S, Baser O, Kwong WJ. Effect of renal function on dosing of non–vitamin K antagonist direct oral anticoagulants among patients with nonvalvular atrial fibrillation. Ann Pharmacother. Forthcoming 2017.

Seyda Seydel G, Kucukoglu O, Altinbas A, Oguz Demir O, Yilmaz S, Akkiz H, Otan E, Sowa JP, Canbay A. Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries. Ann Hepatol. 2016;15(5):662-72.

Ekiz F, Yuksel İ, Arikök AT, Yilmaz B, Altinbas A, Aktas B, Deveci M, Basar O, Coban S, Yuksel O. Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Hepatol Int. 2016;10(4):602-5.

Yilmaz B, Aktas B, Altinbas A, Ginis Z, Ozturk G, Ekiz F, Kilincalp S, Deveci M, Simsek Z, Coban S, Basar O, Yuksel O. The role of M30 in predicting the severity of liver fibrosis and inflammation in chronic hepatitis B patients.  Hepat Mon. 2016;16(9):e35640.

Baser O, Altinbas A, Baser E, Kariburyo F. Economic burden and complications of treated and untreated hepatitis C virus patients in Turkey. Value Health Regional Issues. 2015;7C:42-8.

Wang L, Haider S, Nedrow K, Chambers R, Tawadrous M, Baser O, Simpson KN. HIV economic burden of illness in the Veterans Health Administration population. AIDS Care. 2015;27(1):123-31.

Dasta J, Waikar SS, Xie L, Boklage S, Baser O, Chiodo J, Badawi O. Patterns of treatment and correction of hyponatremia in intensive care-unit patients. J Crit Care. 2015;30(5):1072-9.

Koklu S, Gulsen MT, Tuna Y, Koklu H, Yuksel O, Demir M, Guner R, Dogan Z, Kucukazman M, Poyrazoglu OK, Biyik M, Ozturk NA, Aydogan T, Coban S, Kocaman O, Sapmaz F, Gokturk SH, Karaca C, Demirezer A, Tanoglu A, Yildirim B, Altinbas A, Atak BM, Cosar AM, Alkan E. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B. Aliment Pharmacol Ther. 2015;41(3):310-9.

Altinbaş A, Çoban Ş, Başar Ö, Yüksel O. Utility of M30, an apoptotic serum marker, in liver diseases. Turk J Med Sci. 2015;45(1):6-10.

Altinbas A, Sowa JP, Hasenberg T, Canbay A. The diagnosis and treatment of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol. 2015;61(3):159-69.

Lo Re V 3rd, Wang L, Devine S, Baser O, Olufade T. Hepatic decompensation in patients with HIV/hepatitis B virus (HBV)/hepatitis C virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy. Clin Infect Dis. 2014;59(7):1027-31.

Altinbas A, Baser E, Burkan A, Ertugay E, Kariburyo F, Baser O. Retrospective analysis of total direct medical costs of hepatitis B patients with oral antiviral versus pegylated interferon therapy in Turkey. J Viral Hepat. 2014;21(11):794-801.

Yilmaz B, Basar O, Altınbas A, Ekiz F, Aktas B, Oztürk G, Ginis Z, Coban S, Ucar E, Erarslan E, Coskun Y, Yüksel I, Tuna Y, Yüksel O. The utility of thrombopoietin in predicting liver fibrosis in chronic hepatitis B. Int J Clin Exp Med. 2014;7(5):1430-4.

Caner S, Altınbaş A, Saykı M, Büyükcam F, Yılmaz B, Çakal E, Çoban Ş, Delibaşı T. M30 does not predict the severity of hepatosteatosis, whereas adiponectin level declined with increase of ALT and the severity of hepatic steatosis. J Clin Lab Anal. 2014;28(5):381-5.

Başar O, Yımaz B, Ekiz F, Giniş Z, Altınbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. Clin Res Hepatol Gastroenterol. 2013;37(2):152-8.

Fingas CD, Altinbas A, Schlattjan M, Beilfuss A, Sowa JP, Sydor S, Bechmann LP, Ertle J, Akkiz H, Herzer K, Paul A, Gerken G, Baba HA, Canbay A. Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma. Digestion. 2013;87(3):176-81.

Kahraman A, Sowa JP, Schlattjan M, Sydor S, Pronadl M, Wree A, Beilfuss A, Kilicarslan A, Altinbaş A, Bechmann LP, Syn WK, Gerken G, Canbay A. Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. Clin Sci (Lond). 2013;125(8):391-400.

Altinbas A, Aktas B, Basar O, Yüksel O, Ekiz F, Yılmaz B, Coban S. Is there an association between the measurement of qualitative HBsAg and virologic response in chronic HBV infection? Ann Hepatol. 2012;11(3):320-5.

Şımşek H, Pinar A, Altinbaş A, Alp A, Balaban YH, Büyükaşik Y, Özcebe O, Hasçelık G, Gedıkoğlu G, Tatar G. Alpha-1 antitrypsin deficiency in patients with chronic hepatitis. Turk J Gastroenterol. 2012;23(5):569-73.

Üsküdar O, Altinbaş A, Simşek Z. Endoscopic retrograde cholangiopancreatography with a gastroscope in a case of ectopic opening of common bile duct. Dig Endosc. 2012;24(1):54.

Aktaş B, Başar Ö, Altinbaş A, Ekiz F, Yüksel O. Rabeprazole-induced acute cholestatic liver injury. Turk J Gastroenterol. 2012;23(3):309-10.

Kim B, Shah ND, Kamath PS, et al. Impact of hepatorenal syndrome and hemodialysis on outcome of hospital care in patients with cirrhosis in the MELD era. Am J Transplant. 2011;11(2):124.

Naessens JM, Stroebel RJ, Finnie DM, Shah ND, et al. Effect of multiple chronic conditions among working-age adults. Am J Manag Care. 2011;17(2):118-22.

Englesbe MJ, Dimick JB, Fan Z, Baser O, et al. Case mix, quality and high-cost kidney transplant patients. Am J Transplant. 2009;9(5):1108-14.

Perri RE, Chiorean MV, Fidler JL, Fletcher JG, Talwalkar JA, Stadheim L, Shah ND, Kamath PS. A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology. 2008;47(5):1587-94.

Lee TH, Shah N, Pedersen RA, et al. Survival after liver transplantation: Is racial disparity inevitable? Hepatology. 2007;46(5):1491-97.

To request article copies, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it..